Daan Gene Management
Management criteria checks 1/4
We currently do not have sufficient information about the CEO.
Key information
Luo Huang
Chief executive officer
CN¥1.3m
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 2.5yrs |
| CEO ownership | n/a |
| Management average tenure | no data |
| Board average tenure | 2.6yrs |
Recent management updates
Recent updates
Health Check: How Prudently Does Daan Gene (SZSE:002030) Use Debt?
Oct 24
Daan Gene Co., Ltd. (SZSE:002030) Stock Rockets 31% As Investors Are Less Pessimistic Than Expected
Aug 20Is Daan Gene (SZSE:002030) Weighed On By Its Debt Load?
May 02Daan Gene's (SZSE:002030) Shareholders Have More To Worry About Than Only Soft Earnings
Apr 05Calculating The Fair Value Of Daan Gene Co., Ltd. (SZSE:002030)
Mar 25Daan Gene Co., Ltd. (SZSE:002030) Stock Catapults 29% Though Its Price And Business Still Lag The Industry
Mar 06CEO
Luo Huang (44 yo)
2.5yrs
Tenure
CN¥1,266,800
Compensation
Ms. Luo Huang is Non-Executive Director of Yunkang Group Limited from August 11, 2022. She serves as General Manager at Daan Gene Co., Ltd. She served as Deputy General Manager at Daan Gene Co., Ltd.since...
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| GM & Director | 2.5yrs | CN¥1.27m | no data | |
| Deputy GM | 5.7yrs | CN¥1.13m | no data | |
| Independent Director | 2.6yrs | CN¥120.00k | no data | |
| Supervisor | no data | no data | no data | |
| Vice Chairman Of the Board | 3.8yrs | no data | no data | |
| Chairman of the Supervisory Board | 3.8yrs | no data | no data | |
| Supervisor | 3.8yrs | no data | no data | |
| Director | 2.6yrs | no data | no data | |
| Supervisor | 2.6yrs | no data | no data | |
| Independent Director | 2.6yrs | CN¥120.00k | no data |
2.6yrs
Average Tenure
47.5yo
Average Age
Experienced Board: 002030's board of directors are not considered experienced ( 2.6 years average tenure), which suggests a new board.
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/25 19:50 |
| End of Day Share Price | 2024/12/25 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Daan Gene Co., Ltd. is covered by 14 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Xing Qiu Lin | AJ Securities Co., Ltd |
| Shuchang Liu | Changjiang Securities Co. LTD. |
| Tong Zhang | China Merchants Securities Co. Ltd. |